2 weeks Ago Jira Pliankharom/iStock via Getty Images Harmony Biosciences ( NASDAQ: HRMY ) said on Monday that it has appointed Adam Zaeske as Executive Vice President and Chief Commercial Officer, both to be effective March 31, 2025. The company said that its current CCO, Jeffrey Dierks, is voluntarily stepping down for personal.
